The therapeutic effect of SGLT2 inhibitors in HF may derive from their diuretic effects and beneficial impact on renal physiology, both of which are attractive pathways to explore (Heerspink et al., 2016). This evidence concerns the gene SLC5A2 and hydrops fetalis.